Sona Nanotech Inc. (SNANF)
USD 0.18
(0.0%)
USD 0.18
(0.0%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -2.49 Million CAD | -5.86% |
| 2022 | -2.36 Million CAD | 77.22% |
| 2021 | -10.36 Million CAD | -65.29% |
| 2020 | -6.27 Million CAD | -148.82% |
| 2019 | -2.52 Million CAD | 51.49% |
| 2018 | -5.19 Million CAD | -127.69% |
| 2017 | -2.28 Million CAD | 37.3% |
| 2016 | -3.63 Million CAD | -333.29% |
| 2015 | -840.04 Thousand CAD | 58.45% |
| 2014 | -2.02 Million CAD | -246.16% |
| 2013 | -584.08 Thousand CAD | 87.94% |
| 2012 | -4.84 Million CAD | -595.96% |
| 2011 | -695.96 Thousand CAD | -3.33% |
| 2010 | -673.56 Thousand CAD | 91.92% |
| 2009 | -8.33 Million CAD | -461.33% |
| 2008 | -1.48 Million CAD | -33.58% |
| 2007 | -1.11 Million CAD | -346.72% |
| 2006 | -248.86 Thousand CAD | -6924.02% |
| 2005 | -3543.00 CAD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | -758.98 Thousand CAD | -3.77% |
| 2024 Q2 | -802.53 Thousand CAD | -5.74% |
| 2024 Q3 | -730.77 Thousand CAD | 8.94% |
| 2023 FY | -2.49 Million CAD | -5.86% |
| 2023 Q3 | -843.5 Thousand CAD | -59.62% |
| 2023 Q2 | -528.42 Thousand CAD | -33.33% |
| 2023 Q4 | -731.4 Thousand CAD | 13.29% |
| 2023 Q1 | -396.33 Thousand CAD | -143.02% |
| 2022 Q3 | -793 Thousand CAD | 41.59% |
| 2022 Q1 | -1.13 Million CAD | 17.62% |
| 2022 Q4 | 921.37 Thousand CAD | 216.19% |
| 2022 Q2 | -1.35 Million CAD | -19.92% |
| 2022 FY | -2.36 Million CAD | 77.22% |
| 2021 FY | -10.36 Million CAD | -65.29% |
| 2021 Q1 | -3.68 Million CAD | -8.58% |
| 2021 Q2 | -3.11 Million CAD | 15.53% |
| 2021 Q3 | -2.18 Million CAD | 29.82% |
| 2021 Q4 | -1.37 Million CAD | 37.17% |
| 2020 Q2 | -825.96 Thousand CAD | -150.57% |
| 2020 Q4 | -3.39 Million CAD | -97.74% |
| 2020 FY | -6.27 Million CAD | -148.82% |
| 2020 Q1 | -329.62 Thousand CAD | 15.76% |
| 2020 Q3 | -1.71 Million CAD | -108.05% |
| 2019 Q1 | -346.31 Thousand CAD | 92.67% |
| 2019 Q2 | -441.2 Thousand CAD | -27.4% |
| 2019 Q4 | -391.29 Thousand CAD | 70.84% |
| 2019 FY | -2.52 Million CAD | 51.49% |
| 2019 Q3 | -1.34 Million CAD | -204.14% |
| 2018 FY | -5.19 Million CAD | -127.69% |
| 2018 Q4 | -4.72 Million CAD | -2701.18% |
| 2018 Q3 | -168.66 Thousand CAD | -5.53% |
| 2018 Q2 | -159.82 Thousand CAD | -11.68% |
| 2018 Q1 | -143.1 Thousand CAD | 94.88% |
| 2017 Q3 | 453.39 Thousand CAD | 1022.53% |
| 2017 FY | -2.28 Million CAD | 37.3% |
| 2017 Q4 | -2.79 Million CAD | -715.97% |
| 2017 Q2 | -49.14 Thousand CAD | -146.22% |
| 2017 Q1 | 106.32 Thousand CAD | 136.16% |
| 2016 Q2 | -300.55 Thousand CAD | -107.06% |
| 2016 Q4 | -294.08 Thousand CAD | 89.86% |
| 2016 Q3 | -2.9 Million CAD | -864.89% |
| 2016 FY | -3.63 Million CAD | -333.29% |
| 2016 Q1 | -145.15 Thousand CAD | 65.03% |
| 2015 Q1 | -112.47 Thousand CAD | 89.27% |
| 2015 Q4 | -415.13 Thousand CAD | -176.84% |
| 2015 Q3 | -149.95 Thousand CAD | 7.72% |
| 2015 Q2 | -162.49 Thousand CAD | -44.48% |
| 2015 FY | -840.04 Thousand CAD | 58.45% |
| 2014 Q4 | -1.04 Million CAD | -19.04% |
| 2014 Q1 | -87.35 Thousand CAD | -13.1% |
| 2014 Q2 | -6058.00 CAD | 93.07% |
| 2014 Q3 | -880.42 Thousand CAD | -14433.21% |
| 2014 FY | -2.02 Million CAD | -246.16% |
| 2013 FY | -584.08 Thousand CAD | 87.94% |
| 2013 Q3 | -184.09 Thousand CAD | -13.98% |
| 2013 Q2 | -161.51 Thousand CAD | -0.18% |
| 2013 Q1 | -161.22 Thousand CAD | 12.93% |
| 2013 Q4 | -77.24 Thousand CAD | 58.04% |
| 2012 Q3 | -169.05 Thousand CAD | 38.56% |
| 2012 Q4 | -185.16 Thousand CAD | -9.53% |
| 2012 FY | -4.84 Million CAD | -595.96% |
| 2012 Q1 | -4.2 Million CAD | -2541.54% |
| 2012 Q2 | -275.14 Thousand CAD | 93.46% |
| 2011 Q4 | -159.2 Thousand CAD | 23.94% |
| 2011 Q2 | -158.41 Thousand CAD | 6.27% |
| 2011 Q3 | -209.32 Thousand CAD | -32.13% |
| 2011 FY | -695.96 Thousand CAD | -3.33% |
| 2011 Q1 | -169.02 Thousand CAD | -4.62% |
| 2010 Q1 | -193.93 Thousand CAD | 84.45% |
| 2010 FY | -673.56 Thousand CAD | 91.92% |
| 2010 Q3 | -142.63 Thousand CAD | 18.7% |
| 2010 Q4 | -161.55 Thousand CAD | -13.27% |
| 2010 Q2 | -175.43 Thousand CAD | 9.54% |
| 2009 FY | -8.33 Million CAD | -461.33% |
| 2009 Q2 | -6.55 Million CAD | -1712.29% |
| 2009 Q4 | -1.24 Million CAD | -646.65% |
| 2009 Q3 | -166.99 Thousand CAD | 97.45% |
| 2009 Q1 | -361.95 Thousand CAD | 76.79% |
| 2008 Q2 | 641.06 Thousand CAD | 651.89% |
| 2008 FY | -1.48 Million CAD | -33.58% |
| 2008 Q3 | -450.06 Thousand CAD | -170.21% |
| 2008 Q4 | -1.55 Million CAD | -246.58% |
| 2008 Q1 | -116.15 Thousand CAD | 73.59% |
| 2007 FY | -1.11 Million CAD | -346.72% |
| 2007 Q1 | -146.24 Thousand CAD | -38.32% |
| 2007 Q4 | -439.81 Thousand CAD | -60.66% |
| 2007 Q3 | -273.75 Thousand CAD | -8.68% |
| 2007 Q2 | -251.88 Thousand CAD | -72.23% |
| 2006 Q2 | -89.65 Thousand CAD | -208404.65% |
| 2006 Q3 | -53.42 Thousand CAD | 40.41% |
| 2006 Q4 | -105.73 Thousand CAD | -97.91% |
| 2006 FY | -248.86 Thousand CAD | -6924.02% |
| 2006 Q1 | -43.00 CAD | 0.0% |
| 2005 FY | -3543.00 CAD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| American Bio Medica Corporation | -1.41 Million USD | -77.282% |
| Arrayit Corporation | -3.31 Million USD | 24.609% |
| Atlantic International Corp. | -5.62 Million USD | 55.582% |
| Biocept, Inc. | -32.08 Million USD | 92.21% |
| Bioqual, Inc. | 483.48 Thousand USD | 617.016% |
| CardioGenics Holdings Inc | -1.91 Million USD | -30.441% |
| DermTech, Inc. | -100.88 Million USD | 97.522% |
| Global WholeHealth Partners Corporation | - USD | Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 2.02 Billion USD | 100.123% |
| HTG Molecular Diagnostics, Inc. | -21.59 Million USD | 88.424% |
| iMD Companies, Inc. | -200.63 Thousand USD | -1145.876% |
| IDenta Corp. | 14.64 Thousand USD | 17169.619% |
| Interpace Biosciences, Inc. | 802 Thousand USD | 411.68% |
| Integrative Health Technologies, Inc. | 38.68 Thousand USD | 6560.945% |
| InVitro International | 1553.00 USD | 161057.824% |
| Lumos Diagnostics Holdings Limited | -8.59 Million USD | 70.907% |
| Many Bright Ideas Technologies Inc. | -58.11 Thousand USD | -4201.478% |
| Medical Imaging Corp. | -3.02 Million USD | 17.312% |
| NovelStem International Corp. | -4.18 Million USD | 40.303% |
| Optigenex Inc. | -2.89 Million USD | 13.738% |
| PharmChem, Inc. | 845.1 Thousand USD | 395.784% |
| Proteome Sciences plc | -2.44 Million USD | -2.32% |
| Response Genetics, Inc | -20.18 Million USD | 87.616% |
| Rennova Health, Inc. | -3.29 Million USD | 24.093% |
| RushNet, Inc. | -607.02 Thousand USD | -311.789% |
| ScreenPro Security Inc. | -2.24 Million USD | -11.158% |
| Stella Diagnostics Inc. | -5.7 Million USD | 56.203% |
| StageZero Life Sciences Ltd. | -11.41 Million USD | 78.103% |
| Todos Medical Ltd. | -24.99 Million USD | 89.999% |